Related Experiment Video
Updated: Nov 5, 2025

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation
Anassuya Ramachandran1, Merima Mehić1, Laabiah Wasim2
1Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
Abstract:
Fibrodysplasia ossificans progressiva (FOP) and diffuse intrinsic pontine glioma (DIPG) are debilitating diseases that share causal mutations in ACVR1, a TGF-β family type I receptor. ACVR1R206H is a frequent mutation in both diseases. Pathogenic signaling via the SMAD1/5 pathway is mediated by Activin A, but how the mutation triggers aberrant signaling is not known. We show that ACVR1 is essential for Activin A-mediated SMAD1/5 phosphorylation and is activated by two distinct mechanisms. Wild-type ACVR1 is activated by the Activin type I receptors, ACVR1B/C. In contrast, ACVR1R206H activation does not require upstream kinases, but is predominantly activated via Activin A-dependent receptor clustering, which induces its auto-activation. We use optogenetics and live-imaging approaches to demonstrate Activin A-induced receptor clustering and show it requires the type II receptors ACVR2A/B. Our data provide molecular mechanistic insight into the pathogenesis of FOP and DIPG by linking the causal activating genetic mutation to disrupted signaling.
Insights
Fibrodysplasia ossificans progressiva (FOP) and diffuse intrinsic pontine glioma (DIPG) share ACVR1 mutations. The R206H mutation causes auto-activation via receptor clustering, disrupting SMAD1/5 signaling in these diseases.
Area of Science:
- Molecular biology
- Cell signaling
- Genetics
Background:
- Fibrodysplasia ossificans progressiva (FOP) and diffuse intrinsic pontine glioma (DIPG) are severe diseases.
- Both FOP and DIPG are linked to mutations in ACVR1, a TGF-β family type I receptor.
- The ACVR1R206H mutation is common in both FOP and DIPG, but the mechanism of aberrant signaling is unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which the ACVR1R206H mutation triggers aberrant SMAD1/5 signaling.
- To investigate the role of Activin A in ACVR1 activation in FOP and DIPG.
Main Methods:
- Utilized optogenetics and live-imaging techniques.
- Investigated Activin A-mediated SMAD1/5 phosphorylation.
- Examined ACVR1 activation mechanisms in wild-type and mutant forms.
Main Results:
- ACVR1 is crucial for Activin A-mediated SMAD1/5 phosphorylation.
- Wild-type ACVR1 is activated by ACVR1B/C, while ACVR1R206H auto-activates via Activin A-induced receptor clustering.
- Activin A-induced receptor clustering requires ACVR2A/B.
Conclusions:
- The ACVR1R206H mutation leads to aberrant signaling through Activin A-dependent auto-activation.
- This study provides molecular insights into the pathogenesis of FOP and DIPG by linking genetic mutations to disrupted signaling pathways.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
The Ras Gene
Ras is a...

